vs

Side-by-side financial comparison of Origin Bancorp, Inc. (OBK) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $104.0M, roughly 1.9× Origin Bancorp, Inc.). Origin Bancorp, Inc. runs the higher net margin — 26.6% vs 6.7%, a 19.9% gap on every dollar of revenue. Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 3.9%).

Southern Bancorp is a community development financial institution headquartered in Arkadelphia, Arkansas. It was founded in 1986 as Southern Development Bancorporation, and is often referred to simply as "Southern".

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

OBK vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.9× larger
RGEN
$197.9M
$104.0M
OBK
Higher net margin
OBK
OBK
19.9% more per $
OBK
26.6%
6.7%
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
3.9%
OBK

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
OBK
OBK
RGEN
RGEN
Revenue
$104.0M
$197.9M
Net Profit
$27.7M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
26.6%
6.7%
Revenue YoY
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$0.89
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OBK
OBK
RGEN
RGEN
Q1 26
$104.0M
Q4 25
$103.4M
$197.9M
Q3 25
$109.8M
$188.8M
Q2 25
$83.5M
$182.4M
Q1 25
$94.1M
$169.2M
Q4 24
$78.3M
$174.1M
Q3 24
$90.8M
$154.9M
Q2 24
$96.4M
$154.1M
Net Profit
OBK
OBK
RGEN
RGEN
Q1 26
$27.7M
Q4 25
$29.5M
$13.3M
Q3 25
$8.6M
$14.9M
Q2 25
$14.6M
$14.9M
Q1 25
$22.4M
$5.8M
Q4 24
$14.3M
$-30.3M
Q3 24
$18.6M
$-654.0K
Q2 24
$21.0M
$3.3M
Gross Margin
OBK
OBK
RGEN
RGEN
Q1 26
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Operating Margin
OBK
OBK
RGEN
RGEN
Q1 26
Q4 25
36.2%
9.0%
Q3 25
10.0%
8.9%
Q2 25
22.3%
7.6%
Q1 25
30.4%
3.9%
Q4 24
23.0%
-17.7%
Q3 24
26.1%
-5.1%
Q2 24
27.7%
1.0%
Net Margin
OBK
OBK
RGEN
RGEN
Q1 26
26.6%
Q4 25
28.5%
6.7%
Q3 25
7.9%
7.9%
Q2 25
17.5%
8.2%
Q1 25
23.8%
3.4%
Q4 24
18.2%
-17.4%
Q3 24
20.5%
-0.4%
Q2 24
21.8%
2.2%
EPS (diluted)
OBK
OBK
RGEN
RGEN
Q1 26
$0.89
Q4 25
$0.95
$0.24
Q3 25
$0.27
$0.26
Q2 25
$0.47
$0.26
Q1 25
$0.71
$0.10
Q4 24
$0.45
$-0.55
Q3 24
$0.60
$-0.01
Q2 24
$0.67
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OBK
OBK
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$1.3B
$2.1B
Total Assets
$10.2B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OBK
OBK
RGEN
RGEN
Q1 26
Q4 25
$424.2M
$767.6M
Q3 25
$626.9M
$748.7M
Q2 25
$334.1M
$708.9M
Q1 25
$486.2M
$697.2M
Q4 24
$470.2M
$757.4M
Q3 24
$321.2M
$784.0M
Q2 24
$288.1M
$809.1M
Total Debt
OBK
OBK
RGEN
RGEN
Q1 26
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Stockholders' Equity
OBK
OBK
RGEN
RGEN
Q1 26
$1.3B
Q4 25
$1.2B
$2.1B
Q3 25
$1.2B
$2.1B
Q2 25
$1.2B
$2.1B
Q1 25
$1.2B
$2.0B
Q4 24
$1.1B
$2.0B
Q3 24
$1.1B
$2.0B
Q2 24
$1.1B
$2.0B
Total Assets
OBK
OBK
RGEN
RGEN
Q1 26
$10.2B
Q4 25
$9.7B
$2.9B
Q3 25
$9.8B
$2.9B
Q2 25
$9.7B
$2.9B
Q1 25
$9.8B
$2.9B
Q4 24
$9.7B
$2.8B
Q3 24
$10.0B
$2.8B
Q2 24
$9.9B
$2.9B
Debt / Equity
OBK
OBK
RGEN
RGEN
Q1 26
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OBK
OBK
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OBK
OBK
RGEN
RGEN
Q1 26
Q4 25
$158.9M
$25.7M
Q3 25
$59.3M
$48.1M
Q2 25
$20.6M
$28.6M
Q1 25
$35.6M
$15.0M
Q4 24
$108.5M
$39.2M
Q3 24
$39.6M
$49.3M
Q2 24
$11.9M
$42.2M
Free Cash Flow
OBK
OBK
RGEN
RGEN
Q1 26
Q4 25
$151.1M
$17.6M
Q3 25
$56.8M
$43.4M
Q2 25
$19.6M
$21.5M
Q1 25
$34.8M
$11.4M
Q4 24
$86.4M
$33.6M
Q3 24
$32.2M
$42.3M
Q2 24
$6.5M
$37.4M
FCF Margin
OBK
OBK
RGEN
RGEN
Q1 26
Q4 25
146.0%
8.9%
Q3 25
51.7%
23.0%
Q2 25
23.5%
11.8%
Q1 25
37.0%
6.8%
Q4 24
110.3%
19.3%
Q3 24
35.5%
27.3%
Q2 24
6.8%
24.3%
Capex Intensity
OBK
OBK
RGEN
RGEN
Q1 26
Q4 25
7.6%
4.1%
Q3 25
2.3%
2.5%
Q2 25
1.2%
3.9%
Q1 25
0.8%
2.1%
Q4 24
28.1%
3.2%
Q3 24
8.1%
4.5%
Q2 24
5.6%
3.1%
Cash Conversion
OBK
OBK
RGEN
RGEN
Q1 26
Q4 25
5.38×
1.93×
Q3 25
6.88×
3.23×
Q2 25
1.41×
1.92×
Q1 25
1.59×
2.57×
Q4 24
7.60×
Q3 24
2.13×
Q2 24
0.57×
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OBK
OBK

Net Interest Income$87.2M84%
Noninterest Income$16.8M16%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons